Literature DB >> 28297591

Estrogen Replacement Improves Verbal Memory and Executive Control in Oligomenorrheic/Amenorrheic Athletes in a Randomized Controlled Trial.

Charumathi Baskaran1,2,3, Brooke Cunningham3, Franziska Plessow3, Vibha Singhal2,3, Ryan Woolley3, Kathryn E Ackerman3, Meghan Slattery3, Hang Lee4, Elizabeth A Lawson3, Kamryn Eddy5, Madhusmita Misra2,3.   

Abstract

OBJECTIVE: Both estrogen and exercise may have cognition enhancing benefits; however, young oligomenorrheic/amenorrheic athletes (OA) with estrogen deficiency have not been evaluated for cognitive deficits. Our objective was to determine whether 6 months of estrogen replacement will impact cognitive domains in OA. We hypothesized that estrogen replacement would improve verbal memory and executive control in OA.
METHODS: We performed cognitive assessments at baseline and after 6 months in 48 OA (14-25 years) randomized to estrogen (EST+) (oral 30 µg ethinyl estradiol [n = 16] or transdermal 100 µg 17-β-estradiol patch [n = 13]) or no estrogen (EST-) (n = 19) in an ongoing clinical trial. Neurocognitive testing included California Verbal Learning Test-Second Edition (CVLT-II) (for verbal memory) and Delis-Kaplan Executive Function System Color-Word Interference Test (D-KEFS-CWIT) (executive control).
RESULTS: On average, subjects (mean ± SEM age: 19.9 ± 3.1 years, body mass index: 20.6 ± 2.3 kg/m²) participated in 10.3 ± 5.9 hours per week of weight-bearing activities of their lower limbs. The EST+ group performed better for CVLT-II verbal memory scores for immediate recall over 6 months of therapy compared to EST- (P < .05) even after controlling for baseline scores and age. Changes in D-KEFS-CWIT scores over 6 months did not differ between the groups. However, the EST+ group had greater improvements in inhibition-switching completion time over 6 months compared with the EST- group after controlling for baseline scores and age (P = .01).
CONCLUSIONS: OA show improvements in verbal memory and executive control following 6 months of estrogen replacement. These findings in athletes, who are in their prime of neurocognitive development, underscore the need for future studies exploring cognition in OA. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00946192. © Copyright 2017 Physicians Postgraduate Press, Inc.

Entities:  

Mesh:

Year:  2017        PMID: 28297591      PMCID: PMC6445541          DOI: 10.4088/JCP.15m10544

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  50 in total

Review 1.  An integrative theory of prefrontal cortex function.

Authors:  E K Miller; J D Cohen
Journal:  Annu Rev Neurosci       Date:  2001       Impact factor: 12.449

2.  Enhanced social interactions in rats following chronic, centrally infused oxytocin.

Authors:  D M Witt; J T Winslow; T R Insel
Journal:  Pharmacol Biochem Behav       Date:  1992-11       Impact factor: 3.533

3.  Effects of estrogen on memory function in surgically menopausal women.

Authors:  S M Phillips; B B Sherwin
Journal:  Psychoneuroendocrinology       Date:  1992-10       Impact factor: 4.905

4.  Use of estrogen in young girls with Turner syndrome: effects on memory.

Authors:  J L Ross; D Roeltgen; P Feuillan; H Kushner; G B Cutler
Journal:  Neurology       Date:  2000-01-11       Impact factor: 9.910

5.  Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study.

Authors:  S Asthana; S Craft; L D Baker; M A Raskind; R S Birnbaum; C P Lofgreen; R C Veith; S R Plymate
Journal:  Psychoneuroendocrinology       Date:  1999-08       Impact factor: 4.905

6.  Estrogen and exercise interact to regulate brain-derived neurotrophic factor mRNA and protein expression in the hippocampus.

Authors:  N C Berchtold; J P Kesslak; C J Pike; P A Adlard; C W Cotman
Journal:  Eur J Neurosci       Date:  2001-12       Impact factor: 3.386

7.  Cognitive and behavioral characteristics of turner syndrome: exploring a role for ovarian hormones in female sexual differentiation.

Authors:  Marcia L Collaer; Mitchell E Geffner; Francine R Kaufman; Bruce Buckingham; Melissa Hines
Journal:  Horm Behav       Date:  2002-03       Impact factor: 3.587

Review 8.  Structural and functional brain development and its relation to cognitive development.

Authors:  B J Casey; J N Giedd; K M Thomas
Journal:  Biol Psychol       Date:  2000-10       Impact factor: 3.251

9.  Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study.

Authors:  Valerie Jenkins; Valerie Shilling; Lesley Fallowfield; Anthony Howell; Sam Hutton
Journal:  Psychooncology       Date:  2004-01       Impact factor: 3.894

10.  Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study.

Authors:  Mark A Espeland; Stephen R Rapp; Sally A Shumaker; Robert Brunner; JoAnn E Manson; Barbara B Sherwin; Judith Hsia; Karen L Margolis; Patricia E Hogan; Robert Wallace; Maggie Dailey; Ruth Freeman; Jennifer Hays
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

View more
  8 in total

1.  A cross-sectional analysis of verbal memory and executive control across athletes with varying menstrual status and non-athletes.

Authors:  Charumathi Baskaran; Franziska Plessow; Kathryn E Ackerman; Vibha Singhal; Kamryn T Eddy; Madhusmita Misra
Journal:  Psychiatry Res       Date:  2017-01-20       Impact factor: 3.222

2.  Estrogen administration improves the trajectory of eating disorder pathology in oligo-amenorrheic athletes: A randomized controlled trial.

Authors:  Franziska Plessow; Vibha Singhal; Alexander T Toth; Nadia Micali; Kamryn T Eddy; Madhusmita Misra
Journal:  Psychoneuroendocrinology       Date:  2018-11-16       Impact factor: 4.905

Review 3.  The female athlete triad: review of current literature.

Authors:  Jacqueline Maya; Madhusmita Misra
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2022-02-01       Impact factor: 3.243

4.  Participation in varsity sports, dance, and Greek life associated with menstrual disturbance in a national sample of female college students.

Authors:  Traci L Carson; Vivienne M Hazzard; Erin Finn; Sarah K Lipson
Journal:  J Am Coll Health       Date:  2022-04-05

Review 5.  The Path Towards Progress: A Critical Review to Advance the Science of the Female and Male Athlete Triad and Relative Energy Deficiency in Sport.

Authors:  Mary Jane De Souza; Nicole C A Strock; Emily A Ricker; Kristen J Koltun; Michelle Barrack; Elizabeth Joy; Aurelia Nattiv; Mark Hutchinson; Madhusmita Misra; Nancy I Williams
Journal:  Sports Med       Date:  2021-10-19       Impact factor: 11.928

Review 6.  Functional hypothalamic amenorrhea: Impact on bone and neuropsychiatric outcomes.

Authors:  Clarissa Carvalho Pedreira; Jacqueline Maya; Madhusmita Misra
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-22       Impact factor: 6.055

7.  Effects of Hormonal Contraception Use on Cognitive Functions in Patients With Bulimia Nervosa.

Authors:  Benedicte Nobile; Laurent Maimoun; Isabelle Danielle Jaussent; Maude Seneque; Kathlyne Dupuis-Maurin; Patrick Lefebvre; Phillippe Courtet; Eric Renard; Sebastien Guillaume
Journal:  Front Psychiatry       Date:  2021-05-17       Impact factor: 4.157

Review 8.  The Specificities of Elite Female Athletes: A Multidisciplinary Approach.

Authors:  Carole Castanier; Valérie Bougault; Caroline Teulier; Christelle Jaffré; Sandrine Schiano-Lomoriello; Nancy Vibarel-Rebot; Aude Villemain; Nathalie Rieth; Christine Le-Scanff; Corinne Buisson; Katia Collomp
Journal:  Life (Basel)       Date:  2021-06-26
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.